COL 195

Drug Profile

COL 195

Alternative Names: COL-195; Hydrocodone DETERx® - Collegium Pharmaceutical

Latest Information Update: 24 Jun 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Collegium Pharmaceutical
  • Class Analgesics; Antitussives; Morphinans; Opioid analgesics; Opioid peptides; Small molecules
  • Mechanism of Action Opioid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Pain

Most Recent Events

  • 22 Jun 2016 Topline pharmacokinetics data from a clinical trial in Pain released by Collegium Pharmaceutical
  • 21 Jan 2016 US FDA approves IND application for Hydrocodone DETERx® in Chronic pain
  • 01 Jan 2016 Phase-I/II clinical trials in Pain in USA (PO) (Collegium Form 10-K, March 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top